What if you invested $1000 in TECH on Jan 1, 2020?
Explore hypothetical investment results for stocks, ETFs, and more. See real historical data and share your discoveries.
Historical Annual Returns
Over the past 20 years, Bio-Techne Corporation has delivered an average annual return of 11.1%. The stock peaked in 2021 with a massive +64.9% gain, while investors faced a downturn in 2022 (-31.8%). Overall, the stock finished in the green 11 times out of 20 years.
Avg Return
+11.1%
Win Rate
55%
11W - 9L
Best
+64.9%
2021
Worst
-31.8%
2022
Performance Consistency
About Bio-Techne Corporation
Visit Website ↗Bio-Techne is a leading developer and manufacturer of high-quality purified proteins and reagent solutions, which are used by life science and clinical diagnostic industries.
Key Business Segments
Protein Sciences
Reagents, instruments, and services for protein research.
Diagnostics and Genomics
Clinical diagnostic reagents and genomic analysis.
Key Innovations
- ✓Purified cytokines and growth factors
- ✓Automated Western blot systems
Historical Milestones
Founded as Techne Corporation.
Renamed to Bio-Techne Corporation.